These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2560431)

  • 41. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
    Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
    Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia.
    Parratt JR; Sitsapesan R
    Br J Pharmacol; 1986 Apr; 87(4):621-2. PubMed ID: 3011165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opiate antagonist--receptor interaction unchanged by acute or chronic opiate treatment.
    Dum J; Bläsig J; Meyer G; Herz A
    Eur J Pharmacol; 1979 May; 55(4):375-83. PubMed ID: 223853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
    Dourish CT; O'Neill MF; Coughlan J; Kitchener SJ; Hawley D; Iversen SD
    Eur J Pharmacol; 1990 Jan; 176(1):35-44. PubMed ID: 2311658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mr 2033 CL--a novel non-morphine-like opioid analgesic.
    Stockhaus K; Ensinger HA; Gaida W; Jennewein HM; Merz H
    NIDA Res Monogr; 1983 Apr; 43():144-9. PubMed ID: 6135993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo evidence for benzomorphan-selective receptors in rats.
    Gmerek DE; Cowan A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antisense confirmation of mu- and kappa-opioid receptor mediation of morphine's effects on body temperature in rats.
    Chen XH; Geller EB; DeRiel JK; Liu-Chen LY; Adler MW
    Drug Alcohol Depend; 1996 Dec; 43(3):119-24. PubMed ID: 9023067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Difference in sensitivity of the mu and kappa systems in cafeteria rats.
    Mandenoff A; Bertiere MC; Betoulle D; Apfelbaum M
    Neuropeptides; 1984 Dec; 5(1-3):265-8. PubMed ID: 6099508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC; Husbands SM
    J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tripeptides acting on opioid receptors in rat colon.
    Moritoki H; Takei M; Kotani M; Kiso Y; Ishida Y; Endoh K
    Eur J Pharmacol; 1984 Apr; 100(1):29-39. PubMed ID: 6202530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
    Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.